Biological inactivation by faeces of antimicrobial drugs applicable in selective decontamination of the digestive tract
- 1 December 1984
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 14 (6) , 605-612
- https://doi.org/10.1093/jac/14.6.605
Abstract
The in-vitro inactivation of seven antimicrobial drugs by human faecal substance has been investigated. Nalidixic acid, colistin, neomycin, tobramycin, temocillin, trimethoprim, and aztreonam were separately mixed in graded concentrations with faecal suspensions prepared from faeces of eight healthy volunteers. Each was mixed separately with a sample of each of the eight suspensions. All seven antimicrobial drugs appeared to be rapidly biologically inactivated by intestinal contents in a dose-dependent fashion, although not all to the same extent. The results may explain why with some unabsorbed or minimally absorbed drugs higher oral doses are required to achieve eradication of Gram-negative bacilli from the digestive tract than others, when selective decontamination (SD) is attempted in clinical practice.Keywords
This publication has 5 references indexed in Scilit:
- Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteriaAntimicrobial Agents and Chemotherapy, 1982
- BRL 17421, a novel beta-lactam antibiotic, highly resistant to beta-lactamases, giving high and prolonged serum levels in humansAntimicrobial Agents and Chemotherapy, 1981
- Selective Antimicrobial Modulation of Human Microbial Flora: Infection Prevention in Patients with Decreased Host Defense Mechanisms by Selective Elimination of Potentially Pathogenic BacteriaThe Journal of Infectious Diseases, 1981
- Infection prevention in granulocytopenic patients by selective decontamination of the digestive tractPublished by Elsevier ,1980
- Infection in Acute Leukemia Patients Receiving Oral Nonabsorbable AntibioticsAntimicrobial Agents and Chemotherapy, 1978